Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases Read more
Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease Read more
InnoCare Announces the Clearance of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 by U.S. FDA Read more
Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business Read more
AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025 Read more
CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease Read more
National Institute for Health and Care Excellence (NICE) issues positive guidance for Kyowa Kirin’s POTELIGEO (mogamulizumab) for the treatment of people living with certain ultra-rare blood cancers Read more